Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilko Weichert

Showing results (341-350 of 504) with videos related to

Pageof 51
Sort By:
Cancer Medicine|August 16, 2014
Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatmentAlbrecht Stenzinger, Nicole Pfarr, Volker Endris, et al.
The Journal of Pathology|December 5, 2009
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expressionAreeg Faggad, Jan Budczies, Oleg Tchernitsa, et al.
Annals of Surgical Oncology|May 24, 2015
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric AdenocarcinomaChristoph Springfeld, Christiane Wiecha, Romy Kunzmann, et al.
The American Journal of Surgical Pathology|May 16, 2017
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell CarcinomaMoritz Jesinghaus, Melanie Boxberg, Björn Konukiewitz, et al.
The European Respiratory Journal|August 31, 2013
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotypeArne Warth, Roland Penzel, Heike Lindenmaier, et al.
Radiation Oncology (London, England)|January 11, 2019
Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experienceJan C Peeken, Christoph Knie, Kerstin A Kessel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 9, 2016
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomasAndreas H Scheel, Manfred Dietel, Lukas C Heukamp, et al.
Cancers|April 30, 2021
Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography ImagingFriederike Jungmann, Georgios A Kaissis, Sebastian Ziegelmayer, et al.
British Journal of Cancer|October 21, 2021
Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancerMeike Kohlruss, Marie Krenauer, Bianca Grosser, et al.
Clinical Genitourinary Cancer|March 18, 2020
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell CarcinomaUlrich Sommer, Markus Eckstein, Johannes Ammann, et al.
Pageof 51

Showing results (341-350 of 504) with videos related to

Sort By:
Pageof 51
Cancer Medicine|August 16, 2014
Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatmentAlbrecht Stenzinger, Nicole Pfarr, Volker Endris, et al.
The Journal of Pathology|December 5, 2009
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expressionAreeg Faggad, Jan Budczies, Oleg Tchernitsa, et al.
Annals of Surgical Oncology|May 24, 2015
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric AdenocarcinomaChristoph Springfeld, Christiane Wiecha, Romy Kunzmann, et al.
The American Journal of Surgical Pathology|May 16, 2017
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell CarcinomaMoritz Jesinghaus, Melanie Boxberg, Björn Konukiewitz, et al.
The European Respiratory Journal|August 31, 2013
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotypeArne Warth, Roland Penzel, Heike Lindenmaier, et al.
Radiation Oncology (London, England)|January 11, 2019
Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experienceJan C Peeken, Christoph Knie, Kerstin A Kessel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 9, 2016
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomasAndreas H Scheel, Manfred Dietel, Lukas C Heukamp, et al.
Cancers|April 30, 2021
Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography ImagingFriederike Jungmann, Georgios A Kaissis, Sebastian Ziegelmayer, et al.
British Journal of Cancer|October 21, 2021
Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancerMeike Kohlruss, Marie Krenauer, Bianca Grosser, et al.
Clinical Genitourinary Cancer|March 18, 2020
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell CarcinomaUlrich Sommer, Markus Eckstein, Johannes Ammann, et al.
Pageof 51